コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 alcohol use analysis was confined to problem drinkers).
2 .03-0.06] for three levels in very-high-risk drinkers).
3 ohol when avoiding stigmatised identity as a drinker.
4 in the probability of being a heavy alcohol drinker.
5 or thermoregulation and energy metabolism in drinkers.
6 drinking, especially among moderate lifetime drinkers.
7 dentified at higher concentrations in coffee drinkers.
8 isk drinkers, and most (90.2%) were low-risk drinkers.
9 develops in only a small proportion of heavy drinkers.
10 ed to those who were never smokers and never drinkers.
11 est increase in adenocarcinoma among heavier drinkers.
12 e as diagnostic tools to help classify risky drinkers.
13 n the United States are reported to be heavy drinkers.
14 R of 0.63 in women, compared with female non-drinkers.
15 s and cortisol reactivity, relative to light drinkers.
16 at was not observed in nondependent moderate drinkers.
17 fying 18 escalating drinkers and 18 constant drinkers.
18 s risk was more evident in subgroups of ever drinkers.
19 We excluded former drinkers.
20 f 200 mg to reduce heavy drinking in problem drinkers.
21 with the greatest effects noted for harmful drinkers.
22 Results were similar after excluding binge drinkers.
23 ral correlates of alcohol demand among heavy drinkers.
24 tentials in response to beer cues, in social drinkers.
25 59.7]) compared with uninfected nonhazardous drinkers.
26 n heavy drinkers compared with that in light drinkers.
27 lcohol-related dysfunction score among these drinkers.
28 bules relative to youths who remained no/low drinkers.
29 reaction times in heavy compared with light drinkers.
30 the risk of death was increased among coffee drinkers.
31 lower SVR rates in moderate, but not heavy, drinkers.
32 ive and cortisol responses in heavy vs light drinkers.
33 gher in at-risk drinkers than in non-at-risk drinkers.
34 without hepatitis B or C, who were not heavy drinkers.
35 e-standardized prevalence of heavy and binge drinkers.
36 cy to alcohol misuse in punishment-sensitive drinkers.
37 three diseases than non-drinkers or heavier drinkers.
38 n (RR = 1.30; 95% CI: 1.07 to 1.58) than non-drinkers.
39 drinks consumed per week (drinks/week) among drinkers.
40 nd psychosocial markers could identify binge drinkers.
41 [0.05-0.10] for three levels) and high-risk drinkers (0.64 [0.54-0.75] for one level and 0.12 [0.09-
42 t the offspring of mothers who were moderate drinkers (1-6 units alcohol per week during pregnancy (p
43 h never drinkers, the HRs were 1.25 for ever drinkers, 1.24 for current drinkers, and 1.33 for ex-dri
45 at-risk drinkers (24%) versus 61 non-at-risk drinkers (13%) died in the ICU (p = 0.0009 for the compa
46 h 18 males; 40+ years of age; smokers and/or drinkers (15+ cigarettes per day and/or 15+ units of alc
47 A total of 48 non-treatment-seeking heavy drinkers (16 women) who met DSM-IV criteria for alcohol
48 tion) of the respondents were very-high-risk drinkers, 2.5% were high-risk drinkers, 4.8% were modera
49 of alcohol consumption were defined: 1) non-drinker; 2) </=1 glass/week; 3) >1 glass/week and </=1 g
51 tages 2-3 acute kidney injury in 320 at-risk drinkers (29%) and 787 non-at-risk drinkers (71%) at adm
52 very-high-risk drinkers, 2.5% were high-risk drinkers, 4.8% were moderate-risk drinkers, and most (90
53 g density led to a lower population of light drinkers (42.2% at baseline vs. 38.1% at the 50th percen
54 or heavy episodic intake vs never or former drinker; 5.8%, 3.4-9.7 for current alcohol drinker vs ne
55 ow-level drinkers who never binged, moderate drinkers (60-229 drinks/year) who binged had a higher ri
56 0 at-risk drinkers (29%) and 787 non-at-risk drinkers (71%) at admission to the ICU, within 4 days af
58 ht patients (33%) were identified as at-risk drinkers according to the National Institute on Alcohol
59 at Wave 2, particularly among very-high-risk drinkers (adjusted odds ratios 0.27 [95% CI 0.18-0.41] f
62 centage of heavy episodic drinking and total drinkers among population inversely correlated with temp
63 ation with liters of alcohol consumption and drinkers among population once adjusted by potential con
66 Participants were 156 individuals, 86 heavy drinkers and 70 light drinkers, undergoing an initial or
71 ncluded 6,333 cases, while analysis of never drinkers and consumers of < or =10 drinks/day included 8
72 ng consumption of alcohol (ever versus never drinkers and drinks per week), beverages (coffee, green
73 -directed interventions delivered to at-risk drinkers and enforced legislative measures are also effe
76 ubthalamic connectivity differentiates binge drinkers and individuals with alcohol use disorders from
80 scribed differences in trajectories of heavy drinkers and nondrinkers over age; secondary analyses co
81 of individuals who were predominantly reward drinkers and received naltrexone vs placebo had an 83% r
82 rms of reducing mortality among the heaviest drinkers and reducing alcohol-related health inequalitie
83 inical applicability: individuals are reward drinkers and respond to naltrexone if their reward score
84 HIV diagnosis, in addition to self-reported drinkers and smokers as being at higher risk of non-comp
88 sthoracic echocardiography, excluding former drinkers and those with significant valvular disease.
89 r current alcohol drinker vs never or former drinker), and diabetes mellitus (1.16, 1.05-1.30; 3.9%,
90 ge drinking among those who were never binge drinkers, and (3) the onset of hazardous drinking among
91 ere 1.25 for ever drinkers, 1.24 for current drinkers, and 1.33 for ex-drinkers (trend P = 0.031).
92 eiotropy by showing null effects in male non-drinkers, and 4) illustrates a way to measure population
93 er plasma ALT among the most obese, in heavy drinkers, and in individuals carrying three or four stea
96 uming 7 or more drinks per week versus never drinkers as follows: for estrogen receptor-positive (ER+
98 more drinks per day vs abstainers and light drinkers as well as smoking (OR, 4.59; 95% CI, 2.91-7.25
100 king and other potential confounders, coffee drinkers, as compared with nondrinkers, had lower hazard
104 oking status; and, alcohol intake (high-risk drinker based on standard drink units) with having a poo
105 rlying response inhibition among college-age drinkers based on their drinking patterns, despite colle
106 this study was to assess whether young binge drinkers (BD) have impaired macrovascular and microvascu
108 Compared with non-bingers (NBD; n=22), binge drinkers (BD, n=22) showed robust impairments in attenti
110 to selective formation of social ties among drinkers but also seem to reflect interpersonal influenc
111 ) shows that high levels of ethanol in binge drinkers cause a shift in the microbiome that leads to t
112 test behavioural changes occurred in harmful drinkers (change in consumption of -3.7% or -138.2 units
113 c currents (sEPSC) was elevated in abstinent drinkers compared with controls, indicating increased pr
114 isk of non-Hodgkin lymphoma (NHL) in alcohol drinkers compared with nondrinkers, the dose-response re
116 s while the same adaptation metric for heavy drinkers (consuming greater than 60 drinks per month) wa
120 ofessional/managerial occupations (for heavy drinkers: current tax increase, -1.3%; value-based tax,
121 controlled trial, we recruited male harmful drinkers defined by an Alcohol Use Disorders Identificat
122 orted alcohol consumption variables, current drinker, defined as any recurrent drinking behavior, and
123 any recurrent drinking behavior, and regular drinker, defined as the subset of current drinkers who c
124 opposed identities of normal or problematic drinker, defined by propriety rather than health conside
125 their drinking patterns, despite college-age drinkers demonstrating high rates of alcohol-use disorde
126 est compared with the lowest categories of a drinker dietary pattern (OR = 1.21; 95% CI: 1.04, 1.41;
130 ombination as controls (CTR), smokers (SMK), drinkers (DRN), smoking-and-drinking subjects (SAD), mar
134 During fMRI No-Go correct rejections, light drinkers exhibited greater BOLD response than did heavy
135 of the 1-year follow-up period, the at-risk drinkers exhibited poorer survival than the non-at-risk
136 reward sensitivity and stimulation in heavy drinkers exhibiting AUD progression in early mid-adultho
137 Study, a population-based cohort, all coffee drinkers for whom genome-wide association data were avai
139 12-month DSM-IV AUD among 12-month high-risk drinkers from 46.5% (95% CI, 44.3%-48.7%) to 54.5% (95%
140 Serum metabolites can distinguish coffee drinkers from nondrinkers; some caffeine-related metabol
142 dred fifty-eight women (51%) were considered drinkers (> 0.5 g/d of alcohol), and the majority drank
149 ients with these disorders are heavy alcohol drinkers, has revolutionized our concept of these diseas
150 ological studies suggest that regular coffee drinkers have reduced risks of mortality, both CV and al
153 given with no stimulation (NS), in 25 heavy drinkers (HDs) and 23 healthy controls, each of whom und
154 response to alcohol between light and heavy drinkers (HDs), however, have yielded inconsistent resul
155 cts who are both current smokers and current drinkers (HR, 1.45; 95% CI, 1.03-2.05) were associated w
156 ciated with reduced odds of being an alcohol drinker in all groups, but prevalence of alcohol consump
157 azards for the composite outcome for current drinkers in HICs and UMICs (HR 0.84 [0.77-0.92]), but no
158 hibited greater BOLD response than did heavy drinkers in left supplementary motor area (SMA), bilater
159 nit pricing, -7.8%) and lesser impacts among drinkers in professional/managerial occupations (for hea
160 UC was better than EUC alone was for harmful drinkers in routine primary health-care settings, and mi
161 UC was better than EUC alone was for harmful drinkers in routine primary health-care settings, and mi
162 ould have greater effects on mortality among drinkers in routine/manual occupations (particularly for
163 and, from a public health perspective, heavy drinkers in routine/manual occupations are a key group a
165 rmal growth trajectories derived from no/low drinkers indicated that gray matter volumes of lobules V
166 re, cortisol response, Timeline Follow-Back, Drinker Inventory of Consequences-Recent, and DSM-IV alc
168 hol intake), and if the patient is an active drinker, liver elastography can be repeated after a comp
170 modification; for example, relative to light drinkers living in advantaged areas, the risk of alcohol
172 These findings suggest that heavy alcohol drinkers may have dysfunction in brain regions underlyin
175 pplied a novel memory task in which moderate drinkers (N = 30) and treatment-seeking individuals with
176 alographic (EEG) data from a group of social drinkers (n = 31) who performed a PIT task in which they
177 Community-recruited healthy young social drinkers (N = 58) completed four laboratory sessions in
179 lf-reported information: any alcohol intake (drinker/non-drinker status) and the regular quantity of
180 nce: porcine cadaveric mesh odds ratio 5.18, drinker odds ratio 3.62, African American odds ratio 0.2
181 ngth of stay odds ratio 1.11; complications: drinker odds ratio 6.52, porcine cadaveric mesh odds rat
182 n self-reported alcohol intake: nondrinkers, drinkers of </=7, >/=7 to 14, and >/=14 drinks per week.
185 he risk of CVD was elevated for nondrinkers, drinkers of decaffeinated coffee, and those who reported
192 (ie, downward social selection for high-risk drinkers), or a greater risk of harm in individuals of l
193 ed item memory in AUD compared with moderate drinkers (p < 0.001), but enhanced associative memory fo
194 hibited poorer survival than the non-at-risk drinkers (p = 0.0004, as determined by the log-rank test
198 cted in terms of consumption (-3.8 units per drinker per year for the lowest income quintile vs 0.8 u
200 t income quintile (-7.6% or -299.8 units per drinker per year, with a decrease in spending of pound34
201 in consumption of -3.7% or -138.2 units per drinker per year, with a decrease in spending of pound4.
205 h histological parameters (n = 106) in heavy drinkers primarily admitted for alcohol withdrawal befor
206 ith individuals who are predominantly reward drinkers produces significantly higher effect sizes than
208 design, 40 healthy moderate-to-heavy social drinkers received either no alcohol (placebo), 0.4 g/kg
210 a large biopsy-controlled study of excessive drinkers recruited from primary and secondary care, to e
212 ld affect harmful use of alcohol: by current drinkers replacing standard alcoholic beverages with sim
214 not (RR 0.69, 0.62-0.77; p<0.0001; wine-only drinkers RR 0.69, 0.56-0.85; all other drinkers RR 0.72,
216 er risk for clinical AL progression than non-drinkers (RR = 0.52; 95% CI: 0.30 to 0.89), whereas thos
219 esults also suggest that smokers and alcohol drinkers should be identified and targeted for adherence
222 netic resonance imaging in heavy social male drinkers showed that intranasal oxytocin (24 IU) decreas
223 rinking in punishment-sensitive nondependent drinkers.SIGNIFICANCE STATEMENT Many people drink to all
224 ears; 54% black; 46% female), 332 (58%) were drinkers; significantly higher proportions of drinkers w
227 e policy on moderate, hazardous, and harmful drinkers, split into three socioeconomic groups (living
228 olymorphism (SNP) rs671 in ALDH2 and alcohol drinker status (odd ratio (OR)=0.40, P=2.28 x 10(-72)) i
229 on phenotypes (OR=0.79, P=2.47 x 10(-20) for drinker status and beta=-0.19, P=1.91 x 10(-35) for drin
230 information: any alcohol intake (drinker/non-drinker status) and the regular quantity of drinks consu
231 drinks/week and OR=0.96, P=4.08 x 10(-5) for drinker status), and rs4665985 (beta=0.04, P=2.26 x 10(-
233 tiator model should be revised: in high-risk drinkers, stimulant and rewarding alcohol responses even
234 r PVN neurons in both controls and abstinent drinkers, suggesting a lack of tolerance to acute ethano
235 of sIPSCs in controls, but not in abstinent drinkers, suggesting a tolerance to ethanol-enhanced GAB
236 the quantity of liquid consumed; by current drinkers switching to no alcohol alternatives for part o
244 individuals, 86 heavy drinkers and 70 light drinkers, undergoing an initial oral alcohol challenge t
245 sode on CB1R availability, 20 healthy social drinkers underwent [(18)F]MK-9470-positron emission tomo
247 r drinker; 5.8%, 3.4-9.7 for current alcohol drinker vs never or former drinker), and diabetes mellit
248 d in a fluoridated area for nonbottled water drinkers was 0.51 (95% CI, 0.31 to 0.84; P = 0.008).
249 omparison, the adjusted OR for bottled water drinkers was 1.86 (95% CI, 0.54 to 6.41; P = 0.326).
250 never, former, light, moderate, and at-risk drinkers was 25.1%, 31.8%, 20.9%, 22.2%, and 18.8%, resp
251 nges most of the excess mortality in heavier drinkers was from external causes or the eight disease g
252 ttributable admission or death for excessive drinkers was increased (hazard ratio 6.12, 95% CI 4.45-8
255 or drink, only patients who both smokers and drinkers were associated with reduced survival from PDAC
256 2% of at-risk drinkers and 9% of non-at-risk drinkers were discharged with stages 2-3 acute kidney in
259 Fifty-six overweight and moderate-heavy drinkers were prospectively stratified by genotype (29 A
263 ung (18-25 years) social binge and non-binge drinkers were tested for motor impulsivity and attention
265 rinkers; significantly higher proportions of drinkers were white, male, and with higher levels of edu
266 ome, self-rated "very bad" health, and never drinkers, were statistically significant in predicting l
267 etamine is able to disrupt MRMs in hazardous drinkers when administered immediately after their retri
268 e/manual occupations (particularly for heavy drinkers, where the estimated policy effects on mortalit
269 ce imaging scans, 328 youths remained no/low drinkers, whereas 220 initiated substantial drinking aft
270 s on healthy controls (28.9+/-8.6) for light drinkers while the same adaptation metric for heavy drin
271 would facilitate the identification of heavy drinkers who are likely to respond well to topiramate tr
272 ss-sectional study included 159 young social drinkers who completed a laboratory session in which the
273 ar drinker, defined as the subset of current drinkers who consume at least 2 drinks per week, were co
277 metabolic profile among abstainers and light drinkers who modestly increased their alcohol intake, co
279 ed 110 healthy male habitual moderate coffee drinkers who refrained from drinking coffee on the day p
280 predictions revealed that those young social drinkers who were classified as abstainers showed a grea
281 d cohort study, we included data from 22 005 drinkers who were interviewed in 2001-02 (Wave 1) and re
282 per day at least once per week, and 7 light drinkers, who consumed fewer than 2 drinks per week were
283 several prior studies did not exclude former drinkers, who may have changed alcohol consumption in re
285 cacy and tolerability of topiramate in heavy drinkers whose treatment goal was to reduce drinking to
286 nce characterizes T-cell responses in active drinkers with ARC, whereas IL-4 production prevails in a
289 ucing alcohol drinking and craving among FHP drinkers with beneficial effects that appear to carryove
294 patients aged 18 to 70 years who were heavy drinkers with severe biopsy-proven alcoholic hepatitis,
298 driven by negative reinforcement (ie, relief drinkers) would have a better treatment response to acam
299 driven by positive reinforcement (ie, reward drinkers) would have a better treatment response to nalt
300 m and reduced alcohol consumption and, among drinkers, would be expected to reduce fetal exposure to